Treating Cognitive Impairment and Depression after Stroke: What is the Evidence?

Treating Cognitive Impairment and Depression after Stroke: What is the Evidence? is organized by College of Psychiatric and Neurologic Pharmacists (CPNP) and will be held from May 16, 2019 - Apr 09, 2022. This Course has been approved for a maximum of 1.0 Contact Hours.

Target Audience:
This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary:
Many patients experience cognitive decline after stroke, and over one-third of stroke survivors will develop depression. Cognitive impairment and depression after stroke each increase the risk of disability, worsen stroke survivors' quality of life, and negatively impact medication adherence. The clinical pharmacist can play a vital role in evaluating and treating the growing population of stroke survivors many of whom have cognitive impairment and/or depression. This session will teach concepts to improve clinical pharmacists' care of stroke survivors with cognitive impairment and/or depression.

Course Requirements:
You will proceed through the following steps to satisfactorily complete this course:
• Review the full content of the activity and reflect upon its teachings.
• Complete the post-test at the end of the activity no later than the closing activity date. (login first)
• Complete the evaluation at the end of the activity. (login first)
• If necessary, complete the post-test retest no later than the closing activity date. (login first)
• Receive a passing grade (70%).
• Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

Learning Objectives:
• Explain why cognitive impairment and depression after stroke are important for the patient, the caregiver(s), and the health care system.
• Recall how to evaluate patients at high risk of cognitive impairment or depression after stroke.
• Demonstrate how to appraise the evidence for treating patients with cognitive impairment and depression after stroke.
• Describe how to treat patients with cognitive impairment and depression after stroke.